Flores-Ramirez F, Illenberger J, Martin-Fardon R
Neurobiol Stress. 2024; 33:100695.
PMID: 39640001
PMC: 11617300.
DOI: 10.1016/j.ynstr.2024.100695.
Mohammadkhani A, Qiao M, Borgland S
J Neurosci. 2024; 44(39).
PMID: 39187377
PMC: 11426376.
DOI: 10.1523/JNEUROSCI.0682-24.2024.
Best K, Mojena M, Barr G, Schmidt H, Cohen A
J Neurotrauma. 2021; 39(1-2):1-19.
PMID: 34751584
PMC: 8978570.
DOI: 10.1089/neu.2021.0063.
Matzeu A, Martin-Fardon R
Front Neurol. 2018; 9:720.
PMID: 30210441
PMC: 6121102.
DOI: 10.3389/fneur.2018.00720.
Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R
Neuropsychopharmacology. 2017; 43(5):1010-1020.
PMID: 29052613
PMC: 5854806.
DOI: 10.1038/npp.2017.250.
Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems.
Yeung E, Craggs J, Gizer I
Alcohol Clin Exp Res. 2017; 41(11):1831-1848.
PMID: 29048744
PMC: 5679730.
DOI: 10.1111/acer.13491.
Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations.
Thomas T, Baimel C, Borgland S
Br J Pharmacol. 2017; 175(14):2825-2833.
PMID: 28849596
PMC: 6016629.
DOI: 10.1111/bph.13993.
Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.
Barbacci D, Roux A, Muller L, Jackson S, Post J, Baldwin K
ACS Chem Neurosci. 2017; 8(10):2266-2274.
PMID: 28745861
PMC: 8721872.
DOI: 10.1021/acschemneuro.7b00189.
Neuroclinical Framework for the Role of Stress in Addiction.
Kwako L, Koob G
Chronic Stress (Thousand Oaks). 2017; 1.
PMID: 28653044
PMC: 5482275.
DOI: 10.1177/2470547017698140.
The darkness within: individual differences in stress.
Koob G
Cerebrum. 2015; 2015:4.
PMID: 26034528
PMC: 4445593.
κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.
Whitfield Jr T, Schlosburg J, Wee S, Gould A, George O, Grant Y
J Neurosci. 2015; 35(10):4296-305.
PMID: 25762676
PMC: 4355200.
DOI: 10.1523/JNEUROSCI.1978-13.2015.
Addiction is a Reward Deficit and Stress Surfeit Disorder.
Koob G
Front Psychiatry. 2013; 4:72.
PMID: 23914176
PMC: 3730086.
DOI: 10.3389/fpsyt.2013.00072.
Addiction as a stress surfeit disorder.
Koob G, Buck C, Cohen A, Edwards S, Park P, Schlosburg J
Neuropharmacology. 2013; 76 Pt B:370-82.
PMID: 23747571
PMC: 3830720.
DOI: 10.1016/j.neuropharm.2013.05.024.
The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.
Wand G, Weerts E, Kuwabara H, Wong D, Xu X, McCaul M
Addict Biol. 2012; 18(1):181-92.
PMID: 22264217
PMC: 3337889.
DOI: 10.1111/j.1369-1600.2011.00430.x.
Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers.
Reyes B, Carvalho A, Vakharia K, Van Bockstaele E
Exp Neurol. 2011; 230(1):96-105.
PMID: 21515261
PMC: 3112280.
DOI: 10.1016/j.expneurol.2011.04.001.
Neurobiology of dysregulated motivational systems in drug addiction.
Edwards S, Koob G
Future Neurol. 2010; 5(3):393-401.
PMID: 20563312
PMC: 2886284.
DOI: 10.2217/fnl.10.14.
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S, Koob G
Psychopharmacology (Berl). 2010; 210(2):121-35.
PMID: 20352414
PMC: 2879894.
DOI: 10.1007/s00213-010-1825-8.
Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus.
Reyes B, Chavkin C, Van Bockstaele E
J Comp Neurol. 2008; 512(3):419-31.
PMID: 19009591
PMC: 2592510.
DOI: 10.1002/cne.21880.
A role for brain stress systems in addiction.
Koob G
Neuron. 2008; 59(1):11-34.
PMID: 18614026
PMC: 2748830.
DOI: 10.1016/j.neuron.2008.06.012.
Pronociceptive actions of dynorphin via bradykinin receptors.
Lai J, Luo M, Chen Q, Porreca F
Neurosci Lett. 2008; 437(3):175-9.
PMID: 18450375
PMC: 2767248.
DOI: 10.1016/j.neulet.2008.03.088.